Inogen Statistics
Total Valuation
Inogen has a market cap or net worth of $192.21 million. The enterprise value is $87.21 million.
Important Dates
The last earnings date was Wednesday, November 5, 2025, before market open.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Inogen has 27.15 million shares outstanding. The number of shares has increased by 9.55% in one year.
| Current Share Class | 27.15M |
| Shares Outstanding | 27.15M |
| Shares Change (YoY) | +9.55% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 72.76% |
| Float | 24.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.53 |
| Forward PS | 0.49 |
| PB Ratio | 0.97 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.14, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.14 |
| Quick Ratio | 2.52 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.27% and return on invested capital (ROIC) is -9.04%.
| Return on Equity (ROE) | -13.27% |
| Return on Assets (ROA) | -6.21% |
| Return on Invested Capital (ROIC) | -9.04% |
| Return on Capital Employed (ROCE) | -12.58% |
| Revenue Per Employee | $453,039 |
| Profits Per Employee | -$33,129 |
| Employee Count | 766 |
| Asset Turnover | 1.13 |
| Inventory Turnover | 7.92 |
Taxes
| Income Tax | -726,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.55% in the last 52 weeks. The beta is 1.81, so Inogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | -25.55% |
| 50-Day Moving Average | 7.94 |
| 200-Day Moving Average | 7.45 |
| Relative Strength Index (RSI) | 42.03 |
| Average Volume (20 Days) | 210,882 |
Short Selling Information
The latest short interest is 730,930, so 2.69% of the outstanding shares have been sold short.
| Short Interest | 730,930 |
| Short Previous Month | 684,907 |
| Short % of Shares Out | 2.69% |
| Short % of Float | 3.04% |
| Short Ratio (days to cover) | 3.98 |
Income Statement
In the last 12 months, Inogen had revenue of $347.03 million and -$25.38 million in losses. Loss per share was -$0.98.
| Revenue | 347.03M |
| Gross Profit | 155.32M |
| Operating Income | -30.45M |
| Pretax Income | -26.10M |
| Net Income | -25.38M |
| EBITDA | -9.75M |
| EBIT | -30.45M |
| Loss Per Share | -$0.98 |
Full Income Statement Balance Sheet
The company has $123.22 million in cash and $18.22 million in debt, giving a net cash position of $105.00 million or $3.87 per share.
| Cash & Cash Equivalents | 123.22M |
| Total Debt | 18.22M |
| Net Cash | 105.00M |
| Net Cash Per Share | $3.87 |
| Equity (Book Value) | 197.18M |
| Book Value Per Share | 7.26 |
| Working Capital | 138.77M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$13.29 million and capital expenditures -$11.15 million, giving a free cash flow of -$24.44 million.
| Operating Cash Flow | -13.29M |
| Capital Expenditures | -11.15M |
| Free Cash Flow | -24.44M |
| FCF Per Share | -$0.90 |
Full Cash Flow Statement Margins
Gross margin is 44.76%, with operating and profit margins of -8.77% and -7.31%.
| Gross Margin | 44.76% |
| Operating Margin | -8.77% |
| Pretax Margin | -7.52% |
| Profit Margin | -7.31% |
| EBITDA Margin | -2.81% |
| EBIT Margin | -8.77% |
| FCF Margin | n/a |
Dividends & Yields
Inogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.55% |
| Shareholder Yield | -9.55% |
| Earnings Yield | -13.20% |
| FCF Yield | -12.72% |
Analyst Forecast
The average price target for Inogen is $11.00, which is 53.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 53.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Inogen has an Altman Z-Score of 1.72 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.72 |
| Piotroski F-Score | 4 |